Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Patients with Parkinson’s may experience “on-off” fluctuations, which are changes in the ability to move and are usually related to medication timing. These fluctuations can result in the…
52 months after a suggestive brain scan indicated a strong possibility of CTE in a former NFL player, the diagnosis has been confirmed by autopsy following the ex-players…
Eleanor K. Orehek, MD shares details of some new delivery methods for carbidopa/levodopa in patients with Parkinson’s disease. Among the promising new technologies are a credit card-sized wearable…
Researchers from University College London (UCL) are working on a project with the lofty goal of analyzing the entirety of a brain’s neuronal activity in real time. Most…
Irene Malaty, MD, Associate Professor of Neurology at the University of Florida, explains how doctors can help manage their patient’s motor fluctuations. A doctor can prescribe an alternative…
Charles Munyon, director of functional restorative neurosurgery at Temple University Hospital, MD, discusses movement disorders and their current treatments. Degenerative disorders involve the death of brain cells over…
Movement disorders aren’t always identified as irregular movements. Freezing in Parkinson’s disease (or motor block) happens when there is a brief temporary inability to move. Many patients with…
